Jean-Louis Falco
Chief Executive Officer at CliniGenetics SA
Profile
Jean-Louis Falco is the founder of CliniGenetics SA. He is currently the Chairman at Aurex SAS and SAS Linerbenne.
Previously, he served as the Chief Executive Officer at Arteria SA (France) and as a Member-Supervisory Board at Bleecker SA. He graduated from Université Paris Dauphine-PSL.
Jean-Louis Falco active positions
| Companies | Position | Start |
|---|---|---|
CliniGenetics SA
 CliniGenetics SA Pharmaceuticals: MajorHealth Technology CliniGenetics SA discovers and develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases. The firm identifies and develops new pathways and products for the treatment of vascular diseases. CliniGenetics was founded in 2000 and is headquartered in Nimes, France. | Chief Executive Officer | - |
| Aurex SAS | Chairman | - |
| SAS Linerbenne | Chairman | - |
Former positions of Jean-Louis Falco
| Companies | Position | End |
|---|---|---|
| Arteria SA (France) | Chief Executive Officer | - |
| BLEECKER | Director/Board Member | - |
Training of Jean-Louis Falco
| Université Paris Dauphine-PSL | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BLEECKER | Finance |
| Private companies | 4 |
|---|---|
CliniGenetics SA
CliniGenetics SA Pharmaceuticals: MajorHealth Technology CliniGenetics SA discovers and develops novel therapeutics for the treatment of cardiovascular, cerebrovascular, and lower limb ischemic diseases. The firm identifies and develops new pathways and products for the treatment of vascular diseases. CliniGenetics was founded in 2000 and is headquartered in Nimes, France. | Health Technology |
| Arteria SA (France) | Commercial Services |
| Aurex SAS | |
| SAS Linerbenne |
- Stock Market
- Insiders
- Jean-Louis Falco
